Sabah joined Alector in October 2016. He has served as our Chief Business Officer since January 2018 and previously as our Vice President of Business Development and Operations since October 2016. From January 2016 until October 2016, Sabah served as a consultant to a number of biotechnology companies. Sabah previously served as Head of Global Sales and Business Development at biotechnology company Ariosa Diagnostics, Inc. (now a member of Roche Holding AG) from October 2015 to January 2016, and as Director of Business Development from September 2012 to October 2015. Sabah holds a Ph.D. in Genetics and Genomics from Duke University, an M.B.A. from Stanford University Graduate School of Business, and a B.S. in Genetics from the University of Kansas.